Clinical Trials in Baltimore

Showing 1-20 of 20,142 trials

Study of Treatment for HPV16+ ASC-US or LSIL

NCT03913117

Phase I clinical trial to assess safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN protein vaccinations, and to seek the appropriate dose of the pNGVL4aCRTE6E7L2 DNA vaccine

ASC-USLSIL

University of Alabama at Birmingham30 participantsStarted Jul 2023

Birmingham, Alabama, United States • Baltimore, Maryland, United States

Active Not RecruitingPhase 1/2< 1 mile

A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

NCT06828666

The purpose of this study is to evaluate the safety profile of BRC-OA for pain treatment in patients with mild to severe OA of the knee, focusing particularly on two distinct doses. Alongside safety assessments, the study also aims to investigate the initial efficacy of BRC-OA in treating pain among these patients. The study product is a cryopreserved devitalized adipose tissue allograft (BRC-OA). BRC-OA is composed of a devitalized human adipose particulate that retains the inherent properties of adipose such as tissue architecture, extracellular matrix, and signaling molecules.

Osteoarthritis of Knee

Britecyte42 participantsStarted May 2025

Baltimore, Maryland, United States • Hagerstown, Maryland, United States • Oxon Hill, Maryland, United States +4 more locations

Study of Treatment for HPV16+ ASC-US or LSIL

A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

Find Trials by Condition in Baltimore

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

MitraClip REPAIR MR Study

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer

A Study of BI 3810944 in Patients With Advanced Cancer

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Dissemination and Implementation of the Bright Bodies Intervention for Childhood Obesity

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)